靶向急性肾损伤：现有和新型生物标志物的创新方法能否改变范式？
Targeting Acute Kidney Injury: Can an Innovative Approach to Existing and Novel Biomarkers Shift the Paradigm?
机构信息
Children's Healthcare of Atlanta, Division of Critical Care, Department of Pediatrics, Emory School of Medicine, Atlanta, Georgia, USA,
出版信息
Nephron. 2019;143(3):207-210. doi: 10.1159/000500421. Epub 2019 May 7.
PMID:31064003
Abstract
Acute kidney injury (AKI) continues to be an epidemic problem among hospitalized patients. Diagnostic stasis has, in part, contributed to the poor outcomes associated with AKI. Incorporation of newer diagnostic methodology, longitudinal assessment of markers of AKI alone and in combination may improve appreciation of patient risk and the speed of recognition, augment the precision of diagnosis, and target management.
摘要
急性肾损伤（AKI）仍然是住院患者中的一个普遍问题。部分原因是诊断的停滞不前导致 AKI 相关不良预后。新的诊断方法的应用，对 AKI 标志物的纵向评估，单独和联合使用，可能会提高对患者风险的认识和识别速度，提高诊断的准确性，并针对治疗。
Zotero 插件